This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Miller MR, McNamara RL, Segal JB, et al. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials. J Fam Pract 2000 Nov;49(11):1033-46. (PubMed® Abstract)
Robinson KA, McNamara RL, Bass EB, et al. Evidence-based practice centers: production of evidence report on management of atrial fibrillation. AACN Clin Issues 2001 Nov;12(4):618-27. (PubMed® Abstract)
Segal JB, McNamara RL, Miller MR, et al. The evidence regarding the drugs used for ventricular rate control. J Fam Pract 2000 Jan;49(1):47-59. (PubMed® Abstract)
Segal JB, McNamara RL, Miller MR, et al. Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med 2000 Jan;15(1):56-67. (PubMed® Abstract)
Segal JB, McNamara RL, Miller MR, et al. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Cochrane Database Syst Rev 2001;(1):CD001938. (PubMed® Abstract)
Return to Topic Page